Insider Buying: Paragon Care MD & Director Bought AU$541k Of Shares

Simply Wall St.

Dec 25, 2025

Potential Paragon Care Limited (ASX:PGC) shareholders may wish to note that the MD & Director, David Collins, recently bought AU$541k worth of stock, paying AU$0.18 for each share. However, it only...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2594075984"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2594075984\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2594075984?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6031000-choice1-main-header/1585186892307","is_english":true,"pubTime":"2025-12-25 04:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2594075984","market":"us","top_or_hot":-1,"title":"Insider Buying: Paragon Care MD & Director Bought AU$541k Of Shares","media":"Simply Wall St.","content":"<div>\n<p>Potential Paragon Care Limited (ASX:PGC) shareholders may wish to note that the MD & Director, David Collins, recently bought AU$541k worth of stock, paying AU$0.18 for each share.    However, it only...</p>\n\n<a href=\"https://simplywall.st/stocks/au/healthcare/asx-pgc/paragon-care-shares/news/insider-buying-paragon-care-md-director-bought-au541k-of-sha\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Insider Buying: Paragon Care MD & Director Bought AU$541k Of Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInsider Buying: Paragon Care MD & Director Bought AU$541k Of Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-25 04:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/au/healthcare/asx-pgc/paragon-care-shares/news/insider-buying-paragon-care-md-director-bought-au541k-of-sha><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Potential Paragon Care Limited (ASX:PGC) shareholders may wish to note that the MD & Director, David Collins, recently bought AU$541k worth of stock, paying AU$0.18 for each share.    However, it only...</p>\n\n<a href=\"https://simplywall.st/stocks/au/healthcare/asx-pgc/paragon-care-shares/news/insider-buying-paragon-care-md-director-bought-au541k-of-sha\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7103","symbol_name":"保健护理产品经销商","start_time":0,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-pgc/paragon-care-shares/news/insider-buying-paragon-care-md-director-bought-au541k-of-sha","article_id":"2594075984","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6031000-choice1-main-header/1585186892307"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-pgc/paragon-care-shares/news/insider-buying-paragon-care-md-director-bought-au541k-of-sha","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2594075984","pubTimestamp":1766606441,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Potential Paragon Care Limited ( ASX:PGC ) shareholders may wish to note that the MD & Director, David Collins...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7103":"保健护理产品经销商","PGC.AU":"PARAGON CARE LTD","MD":"Pediatrix Medical","BK4196":"保健护理服务"},"translate_title":"内幕购买：Paragon Care董事总经理兼董事购买了54.1万澳元的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MD":1.5,"PGC.AU":1},"content_text":"Potential Paragon Care Limited (ASX:PGC) shareholders may wish to note that the MD & Director, David Collins, recently bought AU$541k worth of stock, paying AU$0.18 for each share.    However, it only increased shareholding by a small percentage, and it wasn't a huge purchase by absolute value, either.     AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Paragon Care Insider Transactions Over The Last Year   In fact, the recent purchase by David Collins was the biggest purchase of Paragon Care shares made by an insider individual in the last twelve months, according to our records.    Even though the purchase was made at a significantly lower price than the recent price (AU$0.21), we still think insider buying is a positive.  Because it occurred at a lower valuation, it doesn't tell us much about whether insiders might find today's price attractive.    In the last twelve months Paragon Care insiders were buying shares, but not selling.    They paid about AU$0.21 on average.     Although they bought at below the recent share price, it is good to see that insiders are willing to invest in the company.       You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below.  If you want to know exactly who sold, for how much, and when, simply click on the graph below!  See our latest analysis for Paragon Care ASX:PGC Insider Trading Volume December 24th 2025 There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of undervalued small cap companies that insiders are buying.   Insider Ownership  Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own.  We usually like to see fairly high levels of insider ownership.   It's great to see that Paragon Care insiders own 68% of the company, worth about AU$241m.  This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.   What Might The Insider Transactions At Paragon Care Tell Us?  It is good to see recent purchasing.    And an analysis of the transactions over the last year also gives us confidence.    When combined with notable insider ownership, these factors suggest Paragon Care insiders are well aligned, and quite possibly think the share price is too low.  Nice!      So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company.    While conducting our analysis, we found that Paragon Care has 1 warning sign and it would be unwise to ignore it.   Of course Paragon Care may not be the best stock to buy. So you may wish to see this free collection of high quality companies. For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.Mobile Infrastructure for Defense and DisasterThe next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.Get the investor briefing before the next round of contractsSponsored On Behalf of CiTechNew: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}